Specific skin lesions in chronic myelomonocytic leukemia: A spectrum of myelomonocytic and dendritic cell proliferations. a study of 42 cases

American Journal of Surgical Pathology

Volumn 36, Issue 9, 2012, Pages 1302-1316

  Vitte, Franck ^a   Fabiani, Bettina ^b   Bénet, Claire ^c   Dalac, Sophie ^d   Balme, Brigitte ^d   Delattre, Claire ^e   Vergier, Béatrice ^f   Beylot Barry, Marie ^f   Vignon Pennamen, Dominique ^c   Ortonne, Nicolas ^g   Algros, Marie Paule ^a   Carlotti, Agnès ^h   Samaleire, Dimitri ⁱ   Frouin, Eric ^j   Levy, Anne ^k   Laroche, Liliane ^k   Theate, Ivan ^l   Monnien, Franck ^m   Mugneret, Francine ⁿ   Petrella, Tony ^n,o  

^a UNIVERSITY HOSPITAL JEAN MINJOZ   (France)

^b HÔPITAL SAINT ANTOINE   (France)

^c SAINT LOUIS HOSPITAL   (France)

^d CENTRE HOSPITALIER LYON SUD   (France)

^e LILLE UNIVERSITY HOSPITAL   (France)

^f BORDEAUX UNIVERSITY HOSPITAL   (France)

^g HENRI MONDOR HOSPITAL   (France)

^h CSL ^*  (France)

ⁱ GRENOBLE UNIVERSITY HOSPITAL   (France)

^j MONTPELLIER UNIVERSITY HOSPITAL   (France)

^k AVICENNE HOSPITAL   (France)

^l CSL   (Belgium)

^m UNIVERSITY HOSPITAL OF BESANÇON   (France)

ⁿ HÔPITAL DU BOCAGE   (France)

^o Centre de Pathologie   (France)

more..

Author keywords

CD123; CD1a; CMML; dendritic cells; plasmacytoid dendritic cells; S100; skin

Indexed keywords

TUMOR MARKER;

AGED; ARTICLE; CELL CLONE; CELL PROLIFERATION; CHROMOSOME ABERRATION; CHRONIC MYELOMONOCYTIC LEUKEMIA; CLINICAL TRIAL; COMPARATIVE STUDY; DENDRITIC CELL; EUROPE; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENETICS; HUMAN; KARYOTYPING; MALE; METABOLISM; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; PATHOLOGY; PRESCHOOL CHILD; SKIN; SKIN TUMOR; SURVIVAL RATE;

AGED; AGED, 80 AND OVER; CELL PROLIFERATION; CHILD, PRESCHOOL; CHROMOSOME ABERRATIONS; CLONE CELLS; DENDRITIC CELLS; EUROPE; FEMALE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; KARYOTYPING; LEUKEMIA, MYELOMONOCYTIC, CHRONIC; MALE; MIDDLE AGED; SKIN; SKIN NEOPLASMS; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 84865510256     PISSN: 01475185     EISSN: 15320979     Source Type: Journal    
DOI: 10.1097/PAS.0b013e31825dd4de     Document Type: Article

References (53)

1. Orazi A, Bennett JM, Germing U, et al. Chronic myelomonocytic leukaemia. In: Swerdlow SH, Campo E, Harris NL, et al., eds. WHO Classification of Tumors of Haematopoietic and Lymphoid Tissues. Lyon, France: IARC press; 2008:76-79.
2. Benet C, Gomez A, Aguilar C, et al. Histologic and immunohistologic characterization of skin localization of myeloid disorders: a study of 173 cases. Am J Clin Pathol. 2011;135:278-290.
3. Avivi I, Rosenbaum H, Levy Y, et al. Myelodysplastic syndrome and associated skin lesions: a review of the literature. Leuk Res. 1999;23:323-330. (Pubitemid 29166765)
4. Duguid JK, Mackie MJ, McVerry BA. Skin infiltration associated with chronic myelomonocytic leukaemia. Br J Haematol. 1983; 53:257-264.
5. Hammami H, Zaraa I, El Euch D, et al. Letterer-Siwe disease associated with chronic myelomyonocytic leukemia: a fortuitous association? Acta Dermatovenerol Alp Panonica Adriat. 2010;19: 45-48.
6. Kimura Y, Sugita Y, Seki R, et al. Infant juvenile myelomonocytic leukemia (JMML) with rapid infiltration of multiple organs. Pathol Int. 2010;60:333-335.
7. Mathew RA, Bennett JM, Liu JJ, et al. Cutaneous manifestations in CMML: Indication of disease acceleration or transformation to AML and review of the literature. Leuk Res. 2012;33:72-80.
8. O'Connell DM, Fagan WA, Skinner SM, et al. Cutaneous involvement in chronic myelomonocytic leukemia. Int J Dermatol. 1994;33:628-631. (Pubitemid 24290320)
9. Pont V, Miquel FJ, Grau TC, et al. Skin involvement in chronic myelomonocytic leukaemia as a predictor of transformation into acute myeloid leukaemia. J Eur Acad Dermatol Venereol. 2001;15:260-262. (Pubitemid 32898873)
10. Pozo-Roman T, Javier Menarguez-Palanca F, Gomez-Pineda A, et al. Specific cutaneous involvement in the course of chronic myelomonocytic leukemia simultaneously with blastic leukemic transformation. Report of a case with histologic and cytochemical study. J Am Acad Dermatol. 1985;12:943-948. (Pubitemid 15052582)
11. Cho-Vega JH, Medeiros LJ, Prieto VG, et al. Leukemia cutis. Am J Clin Pathol. 2008;129:130-142. (Pubitemid 352038602)
12. Kaddu S, Zenahlik P, Beham-Schmid C, et al. Specific cutaneous infiltrates in patients with myelogenous leukemia: a clinicopathologic study of 26 patients with assessment of diagnostic criteria. J Am Acad Dermatol. 1999;40:966-978. (Pubitemid 29268929)
13. Bacher U, Haferlach T, Schnittger S, et al. Recent advances in diagnosis, molecular pathology and therapy of chronic myelomonocytic leukaemia. Br J Haematol. 2011;143:149-167.
14. Bennett JM, Catovsky D, Daniel MT, et al. Proposals for the classification of the myelodysplastic syndromes. Br J Haematol. 1982;51:189-199. (Pubitemid 12073508)
15. Kolde G, Brocker EB. Multiple skin tumors of indeterminate cells in an adult. J Am Acad Dermatol. 1986;15:591-597. (Pubitemid 16004161)
16. Thomas CG, Patel RM, Bergfeld WF. Cytophagic and S-100 protein immunoreactive myeloid leukemia cutis. J Cutan Pathol. 2010;37:390-395.
17. Baddoura FK, Hanson C, Chan WC. Plasmacytoid monocyte proliferation associated with myeloproliferative disorders. Cancer. 1992;69:1457-1467.
18. Harris NL, Demirjian Z. Plasmacytoid T-zone cell proliferation in a patient with chronic myelomonocytic leukemia. Histologic and immunohistologic characterization. Am J Surg Pathol. 1991;15: 87-95.
19. Horny HP, Kaiserling E, Handgretinger R, et al. Evidence for a lymphotropic nature of circulating plasmacytoid monocytes: findings from a case of CD56+ chronic myelomonocytic leukemia. Eur J Haematol. 1995;54:209-216.
20. Orazi A, Chiu R, O'Malley DP, et al. Chronic myelomonocytic leukemia: The role of bone marrow biopsy immunohistology. Mod Pathol. 2006;19:1536-1545. (Pubitemid 44789921)
21. Kaiserling E, Horny HP, Geerts ML, et al. Skin involvement in myelogenous leukemia: morphologic and immunophenotypic heterogeneity of skin infiltrates. Mod Pathol. 1994;7:771-779.
22. Vermi W, Facchetti F, Rosati S, et al. Nodal and extranodal tumorforming accumulation of plasmacytoid monocytes/interferon-producing cells associated with myeloid disorders. Am J Surg Pathol. 2004;28:585-595. (Pubitemid 38579559)
23. Dargent JL, Delannoy A, Pieron P, et al. Cutaneous accumulation of plasmacytoid dendritic cells associated with acute myeloid leukemia: a rare condition distinct from blastic plasmacytoid dendritic cell neoplasm. J Cutan Pathol. 2011;38:893-898.
24. Petrella T, Facchetti F. Tumoral aspects of plasmacytoid dendritic cells: What do we know in 2009. Autoimmunity. 2010;43:210-214.
25. Malhomme de la Roche H, Lai-Cheong JE, Calonje E, et al. Indeterminate cell histiocytosis responding to total skin electron beam therapy. Br J Dermatol. 2008;158:838-840. (Pubitemid 351415718)
26. Ventarola DJ, Mercer SE, Contard PC, et al. S-100-Negative, CD1a-positive histiocytosis: a new variant with features of both indeterminate cells and interstitial dermal dendrocytes. Arch Dermatol. 2011;147:995-997.
27. Rezk SA, Spagnolo DV, Brynes RK, et al. Indeterminate cell tumor: a rare dendritic neoplasm. Am J Surg Pathol. 2008;32:1868-1876.
28. Amo Y, Kawano N, Takasu H, et al. A case of solitary indeterminate cell histiocytosis. J Dermatol. 2003;30:751-754. (Pubitemid 37370232)
29. Caputo R, Marzano AV, Passoni E, et al. Chemotherapeutic experience in indeterminate cell histiocytosis. Br J Dermatol. 2005;153:206-207. (Pubitemid 41044553)
30. Manente L, Cotellessa C, Schmitt I, et al. Indeterminate cell histiocytosis: a rare histiocytic disorder. Am J Dermatopathol. 1997;19:276-283. (Pubitemid 27250890)
31. Ratzinger G, Burgdorf WH, Metze D, et al. Indeterminate cell histiocytosis: fact or fiction? J Cutan Pathol. 2005;32:552-560. (Pubitemid 41224424)
32. Rodriguez-Jurado R, Vidaurri-de la Cruz H, Duran-Mckinster C, et al. Indeterminate cell histiocytosis. Clinical and pathologic study in a pediatric patient. Arch Pathol Lab Med. 2003;127:748-751. (Pubitemid 36613233)
33. Sidoroff A, Zelger B, Steiner H, et al. Indeterminate cell histiocytosis-a clinicopathological entity with features of both X-and non-X histiocytosis. Br J Dermatol. 1996;134:525-532. (Pubitemid 26090948)
34. Tsai MH, Huang WS, Tsai JJ, et al. Differentiating recurrent or residual nasopharyngeal carcinomas from post-radiotherapy changes with 18-fluoro-2-deoxyglucose positron emission tomography and thallium-201 single photon emission computed tomography in patients with indeterminate computed tomography findings. Anticancer Res. 2003;23:3513-3516. (Pubitemid 36975459)
35. Vener C, Soligo D, Berti E, et al. Indeterminate cell histiocytosis in association with later occurrence of acute myeloblastic leukaemia. Br J Dermatol. 2007;156:1357-1361. (Pubitemid 47029818)
36. Vitelli-Avelar DM, Sathler-Avelar R, Dias JC, et al. Chagasic patients with indeterminate clinical form of the disease have high frequencies of circulating CD3+CD16-CD56+ natural killer T cells and CD4+CD25High regulatory T lymphocytes. Scand J Immunol. 2005;62:297-308.
37. Weng YC, Yen RF, Tsai MH, et al. Detection of recurrent nasopharyngeal carcinomas after radiotherapy with technetium-99m tetrofosmin single photon emission computed tomography in patients with indeterminate magnetic resonance imaging findings. Cancer Invest. 2003;21:695-700. (Pubitemid 37377324)
38. Wood GS, Hu CH, Beckstead JH, et al. The indeterminate cell proliferative disorder: report of a case manifesting as an unusual cutaneous histiocytosis. J Dermatol Surg Oncol. 1985;11:1111-1119. (Pubitemid 16206367)
39. Ozono S, Inada H, Nakagawa S, et al. Juvenile myelomonocytic leukemia characterized by cutaneous lesion containing Langerhans cell histiocytosis-like cells. Int J Hematol. 2011;93:389-393.
40. Segal GH, Mesa MV, Fishleder AJ, et al. Precursor Langerhans cell histiocytosis. An unusual histiocytic proliferation in a patient with persistent non-Hodgkin lymphoma and terminal acute monocytic leukemia. Cancer. 1992;70:547-553.
41. Billings SD, Hans CP, Schapiro BL, et al. Langerhans cell histiocytosis associated with myelodysplastic syndrome in adults. J Cutan Pathol. 2006;33:171-174.
42. Khoury JD, Medeiros LJ, Manning JT, et al. CD56(+) TdT(+) blastic natural killer cell tumor of the skin: a primitive systemic malignancy related to myelomonocytic leukemia. Cancer. 2002;94: 2401-2408. (Pubitemid 34457121)
43. Facchetti F, Jones D, Petrella T. Blastic plasmacytoid dendritic cell neoplasm. In: WHO Classification of Tumors, eds. WHO Classification of Tumors of Haematopoietic and Lymphoid Tissues. Lyon, France: IARC press; 2008:145-147.
44. Jegalian AG, Buxbaum NP, Facchetti F, et al. Blastic plasmacytoid dendritic cell neoplasm in children: diagnostic features and clinical implications. Haematologica. 2010;95:1873-1879.
45. Jaffe R, Pileri SA, Facchetti F, et al. Histiocytic and dendritic cell neoplasms. In: WHO Classification of Tumors, eds. WHO Classification of Tumors of Haematopoietic and Lymphoid Tissues. Lyon, France: IARC press; 2008:354-355.
46. Mori M, Matsushita A, Takiuchi Y, et al. Histiocytic sarcoma and underlying chronic myelomonocytic leukemia: a proposal for the developmental classification of histiocytic sarcoma. Int J Hematol. 2010;92:168-173.
47. Longoni D, D'Amico G, Gaipa G, et al. Commitment of juvenile myelo-monocytic (JMML) leukemic cells to spontaneously differentiate into dendritic cells. Hematol J. 2002;3:302-310. (Pubitemid 36163759)
48. Oehler L, Berer A, Keil F, et al. Generation of dendritic cells from human chronic myelomonocytic leukemia cells in fetal calf serumfree medium. Leuk Lymphoma. 2000;38:577-586. (Pubitemid 30614543)
49. Mohty M, Jarrossay D, Lafage-Pochitaloff M, et al. Circulating blood dendritic cells from myeloid leukemia patients display quantitative and cytogenetic abnormalities as well as functional impairment. Blood. 2001;98:3750-3756.
50. Fujita J, Mizuki M, Otsuka M, et al. Myeloid neoplasm-related gene abnormalities differentially affect dendritic cell differentiation from murine hematopoietic stem/progenitor cells. Immunol Lett. 2011; 136:61-73.
51. Chen YC, Chou JM, Ketterling RP, et al. Histologic and immunohistochemical study of bone marrow monocytic nodules in 21 cases with myelodysplasia. Am J Clin Pathol. 2003;120:874-881. (Pubitemid 37486742)
52. Mongkonsritragoon W, Letendre L, Qian J, et al. Nodular lesions of monocytic component in myelodysplastic syndrome. Am J Clin Pathol. 1998;110:154-162. (Pubitemid 28357653)
53. Vermi W, Bonecchi R, Facchetti F, et al. Recruitment of immature plasmacytoid dendritic cells (plasmacytoid monocytes) and myeloid dendritic cells in primary cutaneous melanomas. J Pathol. 2003;200:255-268. (Pubitemid 36748035)